SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3zyx'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BU5_A_RBFA301_1 (PROTEIN (FLAVODOXIN))	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 7	THR A 201 THR A 327 GLY A 313 ASP A 329	None	0.76A	1bu5A-3zyxA: 2.3	1bu5A-3zyxA: 14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BU5_B_RBFB302_1 (PROTEIN (FLAVODOXIN))	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 8	THR A 201 THR A 327 GLY A 313 ASP A 329	None	0.72A	1bu5B-3zyxA: 2.6	1bu5B-3zyxA: 14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C6Y_B_MK1B524_1 (PROTEIN (PROTEASE))	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.83A	1c6yA-3zyxA: undetectable	1c6yA-3zyxA: 11.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CMA_B_SAMB105_0 (PROTEIN (MET REPRESSOR))	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ARG A 70 LEU A 71 GLU A 444 ALA A 439 GLY A 434	None None None FAD A 600 (-3.5A) FAD A 600 (-4.3A)	1.34A	1cmaA-3zyxA: undetectable 1cmaB-3zyxA: undetectable	1cmaA-3zyxA: 12.23 1cmaB-3zyxA: 12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CMC_A_SAMA105_0 (MET REPRESSOR)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	ALA A 439 GLY A 434 ARG A 70 LEU A 71 GLU A 444	FAD A 600 (-3.5A) FAD A 600 (-4.3A) None None None	1.32A	1cmcA-3zyxA: undetectable 1cmcB-3zyxA: undetectable	1cmcA-3zyxA: 12.23 1cmcB-3zyxA: 12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CMC_B_SAMB105_0 (MET REPRESSOR)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	ARG A 70 LEU A 71 GLU A 444 ALA A 439 GLY A 434	None None None FAD A 600 (-3.5A) FAD A 600 (-4.3A)	1.30A	1cmcA-3zyxA: undetectable 1cmcB-3zyxA: undetectable	1cmcA-3zyxA: 12.23 1cmcB-3zyxA: 12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HBP_A_RTLA184_0 (RETINOL BINDING PROTEIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	LEU A 77 ALA A 429 ALA A 439 VAL A 217 LEU A 71	None None FAD A 600 (-3.5A) None None	1.14A	1hbpA-3zyxA: undetectable	1hbpA-3zyxA: 15.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HXW_B_RITB301_2 (HIV-1 PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.93A	1hxwB-3zyxA: undetectable	1hxwB-3zyxA: 13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RXC_F_URFF2001_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 7	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.05A	1rxcF-3zyxA: undetectable	1rxcF-3zyxA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SA1_B_PODB700_1 (TUBULIN ALPHA CHAIN TUBULIN BETA CHAIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 22 ALA A 447 LEU A 451 MET A 454 VAL A 30	None	0.98A	1sa1A-3zyxA: undetectable 1sa1B-3zyxA: undetectable	1sa1A-3zyxA: 20.70 1sa1B-3zyxA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SA1_D_PODD701_1 (TUBULIN ALPHA CHAIN TUBULIN BETA CHAIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 22 ALA A 447 LEU A 451 MET A 454 VAL A 30	None	1.00A	1sa1C-3zyxA: undetectable 1sa1D-3zyxA: undetectable	1sa1C-3zyxA: 20.70 1sa1D-3zyxA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T7J_A_478A200_1 (POL POLYPROTEIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.80A	1t7jA-3zyxA: undetectable	1t7jA-3zyxA: 13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Y7I_A_SALA502_1 (SALICYLIC ACID-BINDING PROTEIN 2)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	3 / 3	LEU A 224 HIS A 24 LYS A 21	None	0.95A	1y7iA-3zyxA: undetectable	1y7iA-3zyxA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JN3_A_JN3A131_1 (FATTY ACID-BINDING PROTEIN, LIVER)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	VAL A 189 PHE A 185 THR A 121 LEU A 155 VAL A 169	None	1.22A	2jn3A-3zyxA: undetectable	2jn3A-3zyxA: 13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q64_B_1UNB1001_3 (PROTEASE RETROPEPSIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.84A	2q64B-3zyxA: undetectable	2q64B-3zyxA: 11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QAK_A_1UNA1001_1 (PROTEASE RETROPEPSIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.87A	2qakA-3zyxA: undetectable	2qakA-3zyxA: 12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XCT_X_CPFX1020_1 (DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 4	ARG A 67 GLY A 443 GLU A 441 SER A 26	None	1.34A	2xctS-3zyxA: undetectable 2xctU-3zyxA: undetectable	2xctS-3zyxA: 21.81 2xctU-3zyxA: 21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B9M_A_SALA1100_1 (SERUM ALBUMIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 4	LEU A 225 ARG A 70 LEU A 75 ALA A 18	None	1.14A	3b9mA-3zyxA: undetectable	3b9mA-3zyxA: 22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKP_B_478B200_2 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.85A	3ekpB-3zyxA: undetectable	3ekpB-3zyxA: 12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKP_C_478C200_1 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.84A	3ekpC-3zyxA: undetectable	3ekpC-3zyxA: 12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKP_C_478C200_2 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.86A	3ekpD-3zyxA: undetectable	3ekpD-3zyxA: 12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_B_017B200_1 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 9	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.85A	3ektA-3zyxA: undetectable	3ektA-3zyxA: 12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_D_017D200_1 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.84A	3ektC-3zyxA: undetectable	3ektC-3zyxA: 12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_A_URFA254_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.12A	3kvvA-3zyxA: undetectable	3kvvA-3zyxA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_B_URFB254_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.13A	3kvvB-3zyxA: undetectable	3kvvB-3zyxA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_C_URFC254_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.14A	3kvvC-3zyxA: undetectable	3kvvC-3zyxA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_D_URFD254_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.12A	3kvvD-3zyxA: undetectable	3kvvD-3zyxA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_E_URFE254_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.12A	3kvvE-3zyxA: undetectable	3kvvE-3zyxA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_F_URFF254_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.10A	3kvvF-3zyxA: undetectable	3kvvF-3zyxA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OY4_B_017B200_2 (HIV-1 PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.78A	3oy4B-3zyxA: undetectable	3oy4B-3zyxA: 13.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PO7_A_ZONA601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	7 / 8	TYR A 60 LEU A 171 CYH A 172 GLN A 206 PHE A 343 TYR A 398 TYR A 435	FAD A 600 (-4.4A) MBT A 601 (-4.2A) None MBT A 601 (-3.4A) MBT A 601 (-4.7A) MBT A 601 ( 3.6A) MBT A 601 ( 4.6A)	0.19A	3po7A-3zyxA: 65.2	3po7A-3zyxA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PO7_B_ZONB601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	8 / 9	TYR A 60 LEU A 171 CYH A 172 ILE A 198 GLN A 206 PHE A 343 TYR A 398 TYR A 435	FAD A 600 (-4.4A) MBT A 601 (-4.2A) None None MBT A 601 (-3.4A) MBT A 601 (-4.7A) MBT A 601 ( 3.6A) MBT A 601 ( 4.6A)	0.14A	3po7B-3zyxA: 64.8	3po7B-3zyxA: 99.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGL_A_GLYA301_0 (GLYCYL-TRNA SYNTHETASE ALPHA SUBUNIT)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 8	ALA A 442 GLY A 425 THR A 426 ARG A 445 GLU A 427	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	1.38A	3rglA-3zyxA: undetectable	3rglA-3zyxA: 18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S3M_A_DLUA398_1 (PFV INTEGRASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 8	GLY A 16 PRO A 265 GLU A 427 ARG A 36	None FAD A 600 ( 4.7A) None FAD A 600 (-3.8A)	0.99A	3s3mA-3zyxA: undetectable	3s3mA-3zyxA: 20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SO9_A_017A100_2 (HIV-1 PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.93A	3so9B-3zyxA: undetectable	3so9B-3zyxA: 11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SPK_B_TPVB100_1 (HIV-1 PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 9	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.80A	3spkA-3zyxA: undetectable	3spkA-3zyxA: 11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SPK_B_TPVB100_2 (HIV-1 PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.90A	3spkB-3zyxA: undetectable	3spkB-3zyxA: 11.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A79_A_P1BA601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	10 / 12	PRO A 104 TRP A 119 LEU A 164 LEU A 171 CYH A 172 GLN A 206 ILE A 316 PHE A 343 TYR A 398 TYR A 435	None None None MBT A 601 (-4.2A) None MBT A 601 (-3.4A) MBT A 601 (-4.6A) MBT A 601 (-4.7A) MBT A 601 ( 3.6A) MBT A 601 ( 4.6A)	0.33A	4a79A-3zyxA: 65.3	4a79A-3zyxA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A79_B_P1BB601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	10 / 12	PRO A 104 TRP A 119 LEU A 164 LEU A 171 CYH A 172 GLN A 206 ILE A 316 PHE A 343 TYR A 398 TYR A 435	None None None MBT A 601 (-4.2A) None MBT A 601 (-3.4A) MBT A 601 (-4.6A) MBT A 601 (-4.7A) MBT A 601 ( 3.6A) MBT A 601 ( 4.6A)	0.43A	4a79B-3zyxA: 64.7	4a79B-3zyxA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A7A_A_RGZA601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	9 / 11	TYR A 60 LEU A 164 LEU A 171 CYH A 172 GLN A 206 ILE A 316 PHE A 343 TYR A 398 TYR A 435	FAD A 600 (-4.4A) None MBT A 601 (-4.2A) None MBT A 601 (-3.4A) MBT A 601 (-4.6A) MBT A 601 (-4.7A) MBT A 601 ( 3.6A) MBT A 601 ( 4.6A)	0.20A	4a7aA-3zyxA: 65.3	4a7aA-3zyxA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4A7A_B_RGZB601_1 (AMINE OXIDASE [FLAVIN-CONTAINING] B)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	10 / 12	PRO A 104 LEU A 164 LEU A 167 LEU A 171 CYH A 172 GLN A 206 ILE A 316 PHE A 343 TYR A 398 TYR A 435	None None None MBT A 601 (-4.2A) None MBT A 601 (-3.4A) MBT A 601 (-4.6A) MBT A 601 (-4.7A) MBT A 601 ( 3.6A) MBT A 601 ( 4.6A)	0.42A	4a7aB-3zyxA: 64.9	4a7aB-3zyxA: 99.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A7T_F_5FWF1001_1 (SUPEROXIDE DISMUTASE [CU-ZN])	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLU A 366 LYS A 362 PRO A 380 GLU A 379	None	1.36A	4a7tF-3zyxA: undetectable	4a7tF-3zyxA: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DQB_B_017B101_2 (ASPARTYL PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.81A	4dqbB-3zyxA: undetectable	4dqbB-3zyxA: 14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DQC_A_017A101_2 (ASPARTYL PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 9	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.83A	4dqcB-3zyxA: undetectable	4dqcB-3zyxA: 13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DQE_B_017B101_2 (ASPARTYL PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.81A	4dqeB-3zyxA: undetectable	4dqeB-3zyxA: 13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DQH_B_017B101_2 (WILD-TYPE HIV-1 PROTEASE DIMER)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.81A	4dqhB-3zyxA: undetectable	4dqhB-3zyxA: 13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1V_B_URFB1301_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 7	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.08A	4e1vB-3zyxA: undetectable	4e1vB-3zyxA: 20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1V_F_URFF1301_1 (URIDINE PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLY A 438 GLN A 65 ILE A 14 VAL A 440	None FAD A 600 ( 4.8A) FAD A 600 (-4.8A) None	1.07A	4e1vF-3zyxA: undetectable	4e1vF-3zyxA: 20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LL3_A_017A201_2 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.88A	4ll3B-3zyxA: undetectable	4ll3B-3zyxA: 13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_B_017B101_2 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 10	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.82A	4njtB-3zyxA: undetectable	4njtB-3zyxA: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_A_TPVA500_1 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.94A	4njuA-3zyxA: undetectable	4njuA-3zyxA: 11.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJU_C_TPVC500_1 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.95A	4njuC-3zyxA: undetectable	4njuC-3zyxA: 11.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PEV_B_ADNB501_1 (MEMBRANE LIPOPROTEIN FAMILY PROTEIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	VAL A 294 GLY A 57 PHE A 343 GLY A 342 ASP A 330	None FAD A 600 ( 3.8A) MBT A 601 (-4.7A) None None	1.35A	4pevB-3zyxA: 2.5	4pevB-3zyxA: 21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QOI_A_ML1A303_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 8	TYR A 300 TRP A 306 GLY A 342 ILE A 344	None	1.00A	4qoiA-3zyxA: undetectable 4qoiB-3zyxA: undetectable	4qoiA-3zyxA: 19.21 4qoiB-3zyxA: 19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.98A	4qvpH-3zyxA: undetectable 4qvpI-3zyxA: undetectable	4qvpH-3zyxA: 17.68 4qvpI-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.98A	4qvpV-3zyxA: undetectable 4qvpW-3zyxA: undetectable	4qvpV-3zyxA: 17.68 4qvpW-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	4qvvH-3zyxA: undetectable	4qvvH-3zyxA: 17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	4qvvV-3zyxA: undetectable	4qvvV-3zyxA: 17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	4qvyH-3zyxA: undetectable	4qvyH-3zyxA: 17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	4qvyV-3zyxA: undetectable 4qvyW-3zyxA: undetectable	4qvyV-3zyxA: 17.68 4qvyW-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	1.00A	4qw0H-3zyxA: undetectable 4qw0I-3zyxA: undetectable	4qw0H-3zyxA: 17.68 4qw0I-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	4qw0V-3zyxA: undetectable 4qw0W-3zyxA: undetectable	4qw0V-3zyxA: 17.68 4qw0W-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.97A	4qw1H-3zyxA: undetectable 4qw1I-3zyxA: undetectable	4qw1H-3zyxA: 17.68 4qw1I-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.98A	4qw1V-3zyxA: undetectable 4qw1W-3zyxA: undetectable	4qw1V-3zyxA: 17.68 4qw1W-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XT8_A_TMQA302_1 (RV2671)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ASN A 66 GLY A 438 ARG A 70 GLU A 441 GLU A 466	None	1.21A	4xt8A-3zyxA: undetectable	4xt8A-3zyxA: 20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTA_G_MFXG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 7	SER A 26 ARG A 67 GLY A 443 THR A 430 GLU A 441	None	1.48A	5btaA-3zyxA: undetectable 5btaC-3zyxA: undetectable 5btaD-3zyxA: undetectable	5btaA-3zyxA: 22.90 5btaC-3zyxA: 22.90 5btaD-3zyxA: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTA_H_MFXH101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCAC GTAA)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 6	SER A 26 ARG A 67 GLY A 443 THR A 430 GLU A 441	None	1.48A	5btaA-3zyxA: 0.0 5btaB-3zyxA: undetectable 5btaC-3zyxA: undetectable	5btaA-3zyxA: 22.90 5btaB-3zyxA: 20.64 5btaC-3zyxA: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTC_G_CPFG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 6	SER A 26 ARG A 67 GLY A 443 THR A 430 GLU A 441	None	1.47A	5btcA-3zyxA: 0.2 5btcC-3zyxA: undetectable 5btcD-3zyxA: undetectable	5btcA-3zyxA: 22.90 5btcC-3zyxA: 22.90 5btcD-3zyxA: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTC_G_CPFG102_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 6	SER A 26 ARG A 67 GLY A 443 THR A 430 GLU A 441	None	1.49A	5btcA-3zyxA: 0.2 5btcB-3zyxA: undetectable 5btcC-3zyxA: undetectable	5btcA-3zyxA: 22.90 5btcB-3zyxA: 20.64 5btcC-3zyxA: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTI_E_LFXE101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCAC GTAA)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 5	SER A 26 ARG A 67 GLY A 443 THR A 430	None	1.14A	5btiA-3zyxA: undetectable 5btiB-3zyxA: undetectable	5btiA-3zyxA: 22.90 5btiB-3zyxA: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTI_F_LFXF101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 5	SER A 26 ARG A 67 GLY A 443 THR A 430	None	1.08A	5btiC-3zyxA: undetectable 5btiD-3zyxA: undetectable	5btiC-3zyxA: 22.90 5btiD-3zyxA: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.98A	5bxnH-3zyxA: undetectable 5bxnI-3zyxA: undetectable	5bxnH-3zyxA: 17.68 5bxnI-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	5cz7V-3zyxA: undetectable 5cz7W-3zyxA: undetectable	5cz7V-3zyxA: 17.68 5cz7W-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	5d0xV-3zyxA: undetectable	5d0xV-3zyxA: 17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KR0_A_478A101_2 (PROTEASE E35D-APV)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 9	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.83A	5kr0B-3zyxA: undetectable	5kr0B-3zyxA: 12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	5l5fH-3zyxA: undetectable 5l5fI-3zyxA: undetectable	5l5fH-3zyxA: 17.68 5l5fI-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.98A	5l5fV-3zyxA: undetectable 5l5fW-3zyxA: undetectable	5l5fV-3zyxA: 17.68 5l5fW-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	5l66H-3zyxA: undetectable 5l66I-3zyxA: undetectable	5l66H-3zyxA: 17.68 5l66I-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	5l66V-3zyxA: undetectable 5l66W-3zyxA: undetectable	5l66V-3zyxA: 17.68 5l66W-3zyxA: 19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LRB_A_ACRA1003_1 (ALPHA-1,4 GLUCAN PHOSPHORYLASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 6	GLU A 179 PHE A 402 THR A 400 TYR A 401	None	0.98A	5lrbA-3zyxA: undetectable	5lrbA-3zyxA: 19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5T2Z_B_017B201_2 (PROTEASE)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 224 ALA A 20 VAL A 229 GLY A 13 ILE A 14	None None None FAD A 600 (-3.4A) FAD A 600 (-4.8A)	0.83A	5t2zB-3zyxA: undetectable	5t2zB-3zyxA: 11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UBB_A_SAMA301_1 (ALPHA N-TERMINAL PROTEIN METHYLTRANSFERASE 1B)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 5	GLY A 194 ARG A 197 ASP A 123 MET A 122	None	1.35A	5ubbA-3zyxA: 1.5	5ubbA-3zyxA: 16.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIQ_A_HFGA1002_0 (PROLYL-TRNA SYNTHETASE (PRORS))	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	LEU A 414 VAL A 289 PRO A 266 THR A 43 GLY A 41	None None None FAD A 600 (-4.0A) FAD A 600 (-3.2A)	1.25A	5xiqA-3zyxA: undetectable	5xiqA-3zyxA: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YBB_A_SAMA601_1 (TYPE I RESTRICTION-MODIFICA TION SYSTEM METHYLTRANSFERASE SUBUNIT)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 5	PHE A 185 THR A 147 ASP A 153 ASN A 117	None	1.50A	5ybbA-3zyxA: undetectable	5ybbA-3zyxA: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YBB_B_SAMB601_1 (TYPE I RESTRICTION-MODIFICA TION SYSTEM METHYLTRANSFERASE SUBUNIT)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	4 / 7	ALA A 424 GLY A 16 GLY A 11 THR A 428	None None FAD A 600 (-3.1A) None	0.75A	5ybbB-3zyxA: undetectable	5ybbB-3zyxA: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_D8ZA831_0 (GEPHYRIN)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	PHE A 423 ILE A 261 LEU A 414 ILE A 286 MET A 285	None	1.40A	6fgdA-3zyxA: 2.7	6fgdA-3zyxA: 10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 12	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	6hwdH-3zyxA: undetectable 6hwdI-3zyxA: undetectable	6hwdH-3zyxA: 14.38 6hwdI-3zyxA: 13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_V_BO2V301_0 (PROTEASOME SUBUNIT BETA TYPE-2)	3zyx	AMINE OXIDASE [FLAVIN-CONTAINING] B (Homo sapiens)	5 / 11	ALA A 424 GLY A 425 THR A 426 ALA A 429 THR A 428	None FAD A 600 (-3.3A) FAD A 600 (-3.4A) None None	0.99A	6hwdV-3zyxA: undetectable	6hwdV-3zyxA: 14.38

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BU5_A_RBFA301_1","PROTEIN (FLAVODOXIN)","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"THR A 201;THR A 327;GLY A 313;ASP A 329","None","0.76A","1bu5A-3zyxA:2.3","1bu5A-3zyxA:14.12"],["1BU5_B_RBFB302_1","PROTEIN (FLAVODOXIN)","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"THR A 201;THR A 327;GLY A 313;ASP A 329","None","0.72A","1bu5B-3zyxA:2.6","1bu5B-3zyxA:14.12"],["1C6Y_B_MK1B524_1","PROTEIN (PROTEASE);PROTEIN (PROTEASE)","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.83A","1c6yA-3zyxA:undetectable","1c6yA-3zyxA:11.52"],["1CMA_B_SAMB105_0","PROTEIN (MET REPRESSOR)","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ARG A  70;LEU A  71;GLU A 444;ALA A 439;GLY A 434","None;None;None;FAD A 600 (-3.5A);FAD A 600 (-4.3A)","1.34A","1cmaA-3zyxA:undetectable;1cmaB-3zyxA:undetectable","1cmaA-3zyxA:12.23;1cmaB-3zyxA:12.23"],["1CMC_A_SAMA105_0","MET REPRESSOR","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 439;GLY A 434;ARG A  70;LEU A  71;GLU A 444","FAD A 600 (-3.5A);FAD A 600 (-4.3A);None;None;None","1.32A","1cmcA-3zyxA:undetectable;1cmcB-3zyxA:undetectable","1cmcA-3zyxA:12.23;1cmcB-3zyxA:12.23"],["1CMC_B_SAMB105_0","MET REPRESSOR","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ARG A  70;LEU A  71;GLU A 444;ALA A 439;GLY A 434","None;None;None;FAD A 600 (-3.5A);FAD A 600 (-4.3A)","1.30A","1cmcA-3zyxA:undetectable;1cmcB-3zyxA:undetectable","1cmcA-3zyxA:12.23;1cmcB-3zyxA:12.23"],["1HBP_A_RTLA184_0","RETINOL BINDING PROTEIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A  77;ALA A 429;ALA A 439;VAL A 217;LEU A  71","None;None;FAD A 600 (-3.5A);None;None","1.14A","1hbpA-3zyxA:undetectable","1hbpA-3zyxA:15.80"],["1HXW_B_RITB301_2","HIV-1 PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.93A","1hxwB-3zyxA:undetectable","1hxwB-3zyxA:13.42"],["1RXC_F_URFF2001_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.05A","1rxcF-3zyxA:undetectable","1rxcF-3zyxA:19.57"],["1SA1_B_PODB700_1","TUBULIN ALPHA CHAIN;TUBULIN BETA CHAIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A  22;ALA A 447;LEU A 451;MET A 454;VAL A  30","None","0.98A","1sa1A-3zyxA:undetectable;1sa1B-3zyxA:undetectable","1sa1A-3zyxA:20.70;1sa1B-3zyxA:20.98"],["1SA1_D_PODD701_1","TUBULIN ALPHA CHAIN;TUBULIN BETA CHAIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A  22;ALA A 447;LEU A 451;MET A 454;VAL A  30","None","1.00A","1sa1C-3zyxA:undetectable;1sa1D-3zyxA:undetectable","1sa1C-3zyxA:20.70;1sa1D-3zyxA:20.98"],["1T7J_A_478A200_1","POL POLYPROTEIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.80A","1t7jA-3zyxA:undetectable","1t7jA-3zyxA:13.42"],["1Y7I_A_SALA502_1","SALICYLIC ACID-BINDING PROTEIN 2","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",3,"LEU A 224;HIS A  24;LYS A  21","None","0.95A","1y7iA-3zyxA:undetectable","1y7iA-3zyxA:19.58"],["2JN3_A_JN3A131_1","FATTY ACID-BINDING PROTEIN, LIVER","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"VAL A 189;PHE A 185;THR A 121;LEU A 155;VAL A 169","None","1.22A","2jn3A-3zyxA:undetectable","2jn3A-3zyxA:13.92"],["2Q64_B_1UNB1001_3","PROTEASE RETROPEPSIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.84A","2q64B-3zyxA:undetectable","2q64B-3zyxA:11.81"],["2QAK_A_1UNA1001_1","PROTEASE RETROPEPSIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.87A","2qakA-3zyxA:undetectable","2qakA-3zyxA:12.30"],["2XCT_X_CPFX1020_1","DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"ARG A  67;GLY A 443;GLU A 441;SER A  26","None","1.34A","2xctS-3zyxA:undetectable;2xctU-3zyxA:undetectable","2xctS-3zyxA:21.81;2xctU-3zyxA:21.81"],["3B9M_A_SALA1100_1","SERUM ALBUMIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"LEU A 225;ARG A  70;LEU A  75;ALA A  18","None","1.14A","3b9mA-3zyxA:undetectable","3b9mA-3zyxA:22.60"],["3EKP_B_478B200_2","PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.85A","3ekpB-3zyxA:undetectable","3ekpB-3zyxA:12.98"],["3EKP_C_478C200_1","PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.84A","3ekpC-3zyxA:undetectable","3ekpC-3zyxA:12.98"],["3EKP_C_478C200_2","PROTEASE;PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.86A","3ekpD-3zyxA:undetectable","3ekpD-3zyxA:12.98"],["3EKT_B_017B200_1","PROTEASE;PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.85A","3ektA-3zyxA:undetectable","3ektA-3zyxA:12.98"],["3EKT_D_017D200_1","PROTEASE;PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.84A","3ektC-3zyxA:undetectable","3ektC-3zyxA:12.98"],["3KVV_A_URFA254_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.12A","3kvvA-3zyxA:undetectable","3kvvA-3zyxA:19.57"],["3KVV_B_URFB254_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.13A","3kvvB-3zyxA:undetectable","3kvvB-3zyxA:19.57"],["3KVV_C_URFC254_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.14A","3kvvC-3zyxA:undetectable","3kvvC-3zyxA:19.57"],["3KVV_D_URFD254_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.12A","3kvvD-3zyxA:undetectable","3kvvD-3zyxA:19.57"],["3KVV_E_URFE254_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.12A","3kvvE-3zyxA:undetectable","3kvvE-3zyxA:19.57"],["3KVV_F_URFF254_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.10A","3kvvF-3zyxA:undetectable","3kvvF-3zyxA:19.57"],["3OY4_B_017B200_2","HIV-1 PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.78A","3oy4B-3zyxA:undetectable","3oy4B-3zyxA:13.65"],["3PO7_A_ZONA601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",7,"TYR A  60;LEU A 171;CYH A 172;GLN A 206;PHE A 343;TYR A 398;TYR A 435","FAD A 600 (-4.4A);MBT A 601 (-4.2A);None;MBT A 601 (-3.4A);MBT A 601 (-4.7A);MBT A 601 ( 3.6A);MBT A 601 ( 4.6A)","0.19A","3po7A-3zyxA:65.2","3po7A-3zyxA:99.61"],["3PO7_B_ZONB601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",8,"TYR A  60;LEU A 171;CYH A 172;ILE A 198;GLN A 206;PHE A 343;TYR A 398;TYR A 435","FAD A 600 (-4.4A);MBT A 601 (-4.2A);None;None;MBT A 601 (-3.4A);MBT A 601 (-4.7A);MBT A 601 ( 3.6A);MBT A 601 ( 4.6A)","0.14A","3po7B-3zyxA:64.8","3po7B-3zyxA:99.61"],["3RGL_A_GLYA301_0","GLYCYL-TRNA SYNTHETASE ALPHA SUBUNIT","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 442;GLY A 425;THR A 426;ARG A 445;GLU A 427","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","1.38A","3rglA-3zyxA:undetectable","3rglA-3zyxA:18.59"],["3S3M_A_DLUA398_1","PFV INTEGRASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A  16;PRO A 265;GLU A 427;ARG A  36","None;FAD A 600 ( 4.7A);None;FAD A 600 (-3.8A)","0.99A","3s3mA-3zyxA:undetectable","3s3mA-3zyxA:20.41"],["3SO9_A_017A100_2","HIV-1 PROTEASE;HIV-1 PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.93A","3so9B-3zyxA:undetectable","3so9B-3zyxA:11.81"],["3SPK_B_TPVB100_1","HIV-1 PROTEASE;HIV-1 PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.80A","3spkA-3zyxA:undetectable","3spkA-3zyxA:11.81"],["3SPK_B_TPVB100_2","HIV-1 PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.90A","3spkB-3zyxA:undetectable","3spkB-3zyxA:11.81"],["4A79_A_P1BA601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",10,"PRO A 104;TRP A 119;LEU A 164;LEU A 171;CYH A 172;GLN A 206;ILE A 316;PHE A 343;TYR A 398;TYR A 435","None;None;None;MBT A 601 (-4.2A);None;MBT A 601 (-3.4A);MBT A 601 (-4.6A);MBT A 601 (-4.7A);MBT A 601 ( 3.6A);MBT A 601 ( 4.6A)","0.33A","4a79A-3zyxA:65.3","4a79A-3zyxA:99.61"],["4A79_B_P1BB601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",10,"PRO A 104;TRP A 119;LEU A 164;LEU A 171;CYH A 172;GLN A 206;ILE A 316;PHE A 343;TYR A 398;TYR A 435","None;None;None;MBT A 601 (-4.2A);None;MBT A 601 (-3.4A);MBT A 601 (-4.6A);MBT A 601 (-4.7A);MBT A 601 ( 3.6A);MBT A 601 ( 4.6A)","0.43A","4a79B-3zyxA:64.7","4a79B-3zyxA:99.61"],["4A7A_A_RGZA601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",9,"TYR A  60;LEU A 164;LEU A 171;CYH A 172;GLN A 206;ILE A 316;PHE A 343;TYR A 398;TYR A 435","FAD A 600 (-4.4A);None;MBT A 601 (-4.2A);None;MBT A 601 (-3.4A);MBT A 601 (-4.6A);MBT A 601 (-4.7A);MBT A 601 ( 3.6A);MBT A 601 ( 4.6A)","0.20A","4a7aA-3zyxA:65.3","4a7aA-3zyxA:99.61"],["4A7A_B_RGZB601_1","AMINE OXIDASE [FLAVIN-CONTAINING] B","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",10,"PRO A 104;LEU A 164;LEU A 167;LEU A 171;CYH A 172;GLN A 206;ILE A 316;PHE A 343;TYR A 398;TYR A 435","None;None;None;MBT A 601 (-4.2A);None;MBT A 601 (-3.4A);MBT A 601 (-4.6A);MBT A 601 (-4.7A);MBT A 601 ( 3.6A);MBT A 601 ( 4.6A)","0.42A","4a7aB-3zyxA:64.9","4a7aB-3zyxA:99.61"],["4A7T_F_5FWF1001_1","SUPEROXIDE DISMUTASE [CU-ZN]","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLU A 366;LYS A 362;PRO A 380;GLU A 379","None","1.36A","4a7tF-3zyxA:undetectable","4a7tF-3zyxA:16.60"],["4DQB_B_017B101_2","ASPARTYL PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.81A","4dqbB-3zyxA:undetectable","4dqbB-3zyxA:14.32"],["4DQC_A_017A101_2","ASPARTYL PROTEASE;ASPARTYL PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.83A","4dqcB-3zyxA:undetectable","4dqcB-3zyxA:13.65"],["4DQE_B_017B101_2","ASPARTYL PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.81A","4dqeB-3zyxA:undetectable","4dqeB-3zyxA:13.65"],["4DQH_B_017B101_2","WILD-TYPE HIV-1 PROTEASE DIMER","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.81A","4dqhB-3zyxA:undetectable","4dqhB-3zyxA:13.42"],["4E1V_B_URFB1301_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.08A","4e1vB-3zyxA:undetectable","4e1vB-3zyxA:20.19"],["4E1V_F_URFF1301_1","URIDINE PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 438;GLN A  65;ILE A  14;VAL A 440","None;FAD A 600 ( 4.8A);FAD A 600 (-4.8A);None","1.07A","4e1vF-3zyxA:undetectable","4e1vF-3zyxA:20.19"],["4LL3_A_017A201_2","PROTEASE;PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.88A","4ll3B-3zyxA:undetectable","4ll3B-3zyxA:13.42"],["4NJT_B_017B101_2","PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.82A","4njtB-3zyxA:undetectable","4njtB-3zyxA:11.35"],["4NJU_A_TPVA500_1","PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.94A","4njuA-3zyxA:undetectable","4njuA-3zyxA:11.94"],["4NJU_C_TPVC500_1","PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.95A","4njuC-3zyxA:undetectable","4njuC-3zyxA:11.94"],["4PEV_B_ADNB501_1","MEMBRANE LIPOPROTEIN FAMILY PROTEIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"VAL A 294;GLY A  57;PHE A 343;GLY A 342;ASP A 330","None;FAD A 600 ( 3.8A);MBT A 601 (-4.7A);None;None","1.35A","4pevB-3zyxA:2.5","4pevB-3zyxA:21.44"],["4QOI_A_ML1A303_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"TYR A 300;TRP A 306;GLY A 342;ILE A 344","None","1.00A","4qoiA-3zyxA:undetectable;4qoiB-3zyxA:undetectable","4qoiA-3zyxA:19.21;4qoiB-3zyxA:19.21"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.98A","4qvpH-3zyxA:undetectable;4qvpI-3zyxA:undetectable","4qvpH-3zyxA:17.68;4qvpI-3zyxA:19.00"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.98A","4qvpV-3zyxA:undetectable;4qvpW-3zyxA:undetectable","4qvpV-3zyxA:17.68;4qvpW-3zyxA:19.00"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","4qvvH-3zyxA:undetectable","4qvvH-3zyxA:17.68"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","4qvvV-3zyxA:undetectable","4qvvV-3zyxA:17.68"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","4qvyH-3zyxA:undetectable","4qvyH-3zyxA:17.68"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","4qvyV-3zyxA:undetectable;4qvyW-3zyxA:undetectable","4qvyV-3zyxA:17.68;4qvyW-3zyxA:19.00"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","1.00A","4qw0H-3zyxA:undetectable;4qw0I-3zyxA:undetectable","4qw0H-3zyxA:17.68;4qw0I-3zyxA:19.00"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","4qw0V-3zyxA:undetectable;4qw0W-3zyxA:undetectable","4qw0V-3zyxA:17.68;4qw0W-3zyxA:19.00"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.97A","4qw1H-3zyxA:undetectable;4qw1I-3zyxA:undetectable","4qw1H-3zyxA:17.68;4qw1I-3zyxA:19.00"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.98A","4qw1V-3zyxA:undetectable;4qw1W-3zyxA:undetectable","4qw1V-3zyxA:17.68;4qw1W-3zyxA:19.00"],["4XT8_A_TMQA302_1","RV2671","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ASN A  66;GLY A 438;ARG A  70;GLU A 441;GLU A 466","None","1.21A","4xt8A-3zyxA:undetectable","4xt8A-3zyxA:20.42"],["5BTA_G_MFXG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"SER A  26;ARG A  67;GLY A 443;THR A 430;GLU A 441","None","1.48A","5btaA-3zyxA:undetectable;5btaC-3zyxA:undetectable;5btaD-3zyxA:undetectable","5btaA-3zyxA:22.90;5btaC-3zyxA:22.90;5btaD-3zyxA:20.64"],["5BTA_H_MFXH101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCACGTAA","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"SER A  26;ARG A  67;GLY A 443;THR A 430;GLU A 441","None","1.48A","5btaA-3zyxA:0.0;5btaB-3zyxA:undetectable;5btaC-3zyxA:undetectable","5btaA-3zyxA:22.90;5btaB-3zyxA:20.64;5btaC-3zyxA:22.90"],["5BTC_G_CPFG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"SER A  26;ARG A  67;GLY A 443;THR A 430;GLU A 441","None","1.47A","5btcA-3zyxA:0.2;5btcC-3zyxA:undetectable;5btcD-3zyxA:undetectable","5btcA-3zyxA:22.90;5btcC-3zyxA:22.90;5btcD-3zyxA:20.64"],["5BTC_G_CPFG102_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"SER A  26;ARG A  67;GLY A 443;THR A 430;GLU A 441","None","1.49A","5btcA-3zyxA:0.2;5btcB-3zyxA:undetectable;5btcC-3zyxA:undetectable","5btcA-3zyxA:22.90;5btcB-3zyxA:20.64;5btcC-3zyxA:22.90"],["5BTI_E_LFXE101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCACGTAA","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"SER A  26;ARG A  67;GLY A 443;THR A 430","None","1.14A","5btiA-3zyxA:undetectable;5btiB-3zyxA:undetectable","5btiA-3zyxA:22.90;5btiB-3zyxA:20.64"],["5BTI_F_LFXF101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"SER A  26;ARG A  67;GLY A 443;THR A 430","None","1.08A","5btiC-3zyxA:undetectable;5btiD-3zyxA:undetectable","5btiC-3zyxA:22.90;5btiD-3zyxA:20.64"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.98A","5bxnH-3zyxA:undetectable;5bxnI-3zyxA:undetectable","5bxnH-3zyxA:17.68;5bxnI-3zyxA:19.00"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","5cz7V-3zyxA:undetectable;5cz7W-3zyxA:undetectable","5cz7V-3zyxA:17.68;5cz7W-3zyxA:19.00"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","5d0xV-3zyxA:undetectable","5d0xV-3zyxA:17.68"],["5KR0_A_478A101_2","PROTEASE E35D-APV;PROTEASE E35D-APV","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.83A","5kr0B-3zyxA:undetectable","5kr0B-3zyxA:12.53"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","5l5fH-3zyxA:undetectable;5l5fI-3zyxA:undetectable","5l5fH-3zyxA:17.68;5l5fI-3zyxA:19.00"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.98A","5l5fV-3zyxA:undetectable;5l5fW-3zyxA:undetectable","5l5fV-3zyxA:17.68;5l5fW-3zyxA:19.00"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","5l66H-3zyxA:undetectable;5l66I-3zyxA:undetectable","5l66H-3zyxA:17.68;5l66I-3zyxA:19.00"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","5l66V-3zyxA:undetectable;5l66W-3zyxA:undetectable","5l66V-3zyxA:17.68;5l66W-3zyxA:19.00"],["5LRB_A_ACRA1003_1","ALPHA-1,4 GLUCAN PHOSPHORYLASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLU A 179;PHE A 402;THR A 400;TYR A 401","None","0.98A","5lrbA-3zyxA:undetectable","5lrbA-3zyxA:19.64"],["5T2Z_B_017B201_2","PROTEASE","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 224;ALA A  20;VAL A 229;GLY A  13;ILE A  14","None;None;None;FAD A 600 (-3.4A);FAD A 600 (-4.8A)","0.83A","5t2zB-3zyxA:undetectable","5t2zB-3zyxA:11.76"],["5UBB_A_SAMA301_1","ALPHA N-TERMINAL PROTEIN METHYLTRANSFERASE 1B","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"GLY A 194;ARG A 197;ASP A 123;MET A 122","None","1.35A","5ubbA-3zyxA:1.5","5ubbA-3zyxA:16.89"],["5XIQ_A_HFGA1002_0","PROLYL-TRNA SYNTHETASE (PRORS)","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"LEU A 414;VAL A 289;PRO A 266;THR A  43;GLY A  41","None;None;None;FAD A 600 (-4.0A);FAD A 600 (-3.2A)","1.25A","5xiqA-3zyxA:undetectable","5xiqA-3zyxA:21.91"],["5YBB_A_SAMA601_1","TYPE I RESTRICTION-MODIFICATION SYSTEM METHYLTRANSFERASE SUBUNIT","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"PHE A 185;THR A 147;ASP A 153;ASN A 117","None","1.50A","5ybbA-3zyxA:undetectable","5ybbA-3zyxA:23.64"],["5YBB_B_SAMB601_1","TYPE I RESTRICTION-MODIFICATION SYSTEM METHYLTRANSFERASE SUBUNIT","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",4,"ALA A 424;GLY A  16;GLY A  11;THR A 428","None;None;FAD A 600 (-3.1A);None","0.75A","5ybbB-3zyxA:undetectable","5ybbB-3zyxA:23.64"],["6FGD_A_D8ZA831_0","GEPHYRIN","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"PHE A 423;ILE A 261;LEU A 414;ILE A 286;MET A 285","None","1.40A","6fgdA-3zyxA:2.7","6fgdA-3zyxA:10.95"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","6hwdH-3zyxA:undetectable;6hwdI-3zyxA:undetectable","6hwdH-3zyxA:14.38;6hwdI-3zyxA:13.85"],["6HWD_V_BO2V301_0","PROTEASOME SUBUNIT BETA TYPE-2","3zyx","AMINE OXIDASE [FLAVIN-CONTAINING] B","Homo sapiens",5,"ALA A 424;GLY A 425;THR A 426;ALA A 429;THR A 428","None;FAD A 600 (-3.3A);FAD A 600 (-3.4A);None;None","0.99A","6hwdV-3zyxA:undetectable","6hwdV-3zyxA:14.38"]]